Impact of different dose reduction criteria on dose assignment of current DOACs and related outcomes: an analysis from 4-year data of the ETNA-AF Europe programme

Back

EHRA Premium Access

Impact of different dose reduction criteria on dose assignment of current DOACs and related outcomes: an analysis from 4-year data of the ETNA-AF Europe programme

Session: Atrial fibrillation: treatment 1

Topic: Oral Anticoagulation

Speaker: Associate Professor I. Diemberger (Bologna, IT)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Associate Professor Igor Diemberger

Institute of Cardiology University of Bologna, Bologna (Italy)

5 presentations

0 follower

7 more presentations in this session

Effectiveness of photoplethysmography-based rhythm monitoring after atrial fibrillation ablation using a smartphone application

Speaker: Doctor H. Gruwez (Genk, BE)

Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial

Speaker: Doctor A. Rillig (Hamburg, DE)

Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial

Speaker: Doctor S. van Doorn (Utrecht, NL)

Management of edoxaban therapy in patients undergoing emergency/urgent procedures: a subanalysis of the global, prospective, observational, multinational EMIT-AF/VTE programme

Speaker: Professor C. Von Heymann (Berlin, DE)

Difference between cryoballoon and radiofrequency ablations for atrial fibrillation based on electroanatomical mechanisms

Speaker: Doctor M. Kim (Yongin, KR)

Access the full session

Atrial fibrillation: treatment 1

Speakers: Associate Professor I. Diemberger, Doctor H. Gruwez, Doctor A. Rillig, Doctor S. van Doorn, Professor C. Von Heymann...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources